Supernus Pharmaceuticals
SUPN
$30.07
Share price
2.59%
Change (1 day)
-18.42%
Change (1 year)
Categories
Supernus Pharmaceuticals (SUPN) - P/B ratio
P/B ratio as of April 2024 : 1.79
According to Supernus Pharmaceuticals
's latest financial reports the company has a price-to-book ratio of 1.79.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Supernus Pharmaceuticals - P/B ratio (from 2012 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 1.72 | -21.15% |
| 2022-12-31 | 2.18 | 14.47% |
| 2021-12-31 | 1.90 | 6.44% |
| 2020-12-31 | 1.79 | -14.67% |
| 2019-12-31 | 2.09 | -45.45% |
| 2018-12-31 | 3.84 | -49.77% |
| 2017-12-31 | 7.64 | 17.08% |
| 2016-12-31 | 6.52 | -12.83% |
| 2015-12-31 | 7.48 | -14.61% |
| 2014-12-31 | 8.76 | -2.72% |
| 2013-12-31 | 9.01 | 136.22% |
| 2012-12-31 | 3.81 | |
| 2011-12-31 | N/A | |
| 2010-12-31 | N/A | |
| 2009-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 5.12 | 186.70% | 🇺🇸 USA |
 Abbott Laboratories ABT | 4.81 | 169.06% | 🇺🇸 USA |
 Eli Lilly LLY | 64.2 | 3,494.23% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 3.08 | 72.61% | 🇺🇸 USA |
 United Therapeutics UTHR | 1.84 | 2.95% | 🇺🇸 USA |